Literature DB >> 11514007

Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.

T P Hellebust1, E Dale, A Skjønsberg, D R Olsen.   

Abstract

PURPOSE: To evaluate variation of dose to organs at risk for patients receiving fractionated high dose rate gynaecological brachytherapy by using CT-based 3D treatment planning and dose-volume histograms (DVH).
MATERIALS AND METHODS: Fourteen patients with cancer of the uterine cervix underwent three to six CT examinations (mean 4.9) during their course of high-dose-rate brachytherapy using radiographically compatible applicators. The rectal and bladder walls were delineated and DVHs were calculated.
RESULTS: Inter fraction variation of the bladder volume (CV(mean)=44.1%) was significantly larger than the inter fraction variation of the mean dose (CV(mean)=19.9%, P=0.005) and the maximum dose (CV(mean)=17.5%, P=0.003) of the bladder wall. The same trend was seen for rectum, although the figures were not significantly different. Performing CT examinations at four of seven brachytherapy fractions reduced the uncertainty to 4 and 7% for the bladder and rectal doses, respectively. A linear regression analysis showed a significant, negative relationship between time after treatment start and the whole bladder volume (P=0.018), whereas no correlation was found for the rectum. For both rectum and bladder a linear regression analysis revealed a significant, negative relationship between the whole volume and median dose (P<0.05).
CONCLUSION: Preferably a CT examination should be provided at every fraction. However, this is logistically unfeasible in most institutions. To obtain reliable DVHs the patients will in the future undergo 3-4 CT examinations during the course of brachytherapy at our institution. Since this study showed an association between large bladder volumes and dose reductions, the patients will be treated with a standardized bladder volume.

Entities:  

Mesh:

Year:  2001        PMID: 11514007     DOI: 10.1016/s0167-8140(01)00386-3

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  19 in total

Review 1.  Radiation dose-volume effects of the urinary bladder.

Authors:  Akila N Viswanathan; Ellen D Yorke; Lawrence B Marks; Patricia J Eifel; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  In vivo dosimetry: trends and prospects for brachytherapy.

Authors:  G Kertzscher; A Rosenfeld; S Beddar; K Tanderup; J E Cygler
Journal:  Br J Radiol       Date:  2014-07-08       Impact factor: 3.039

3.  Four-Dimensional Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Systematic Review and Meta-Regression Analysis.

Authors:  Fei Li; Dan Shi; Mingwei Bu; Shuangchen Lu; Hongfu Zhao
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

4.  Evaluation of variation of interfraction doses to organs at risk during brachytherapy of cervical cancer.

Authors:  Hari Mukundan; Kirti Tyagi; Deboleena Mukherjee; R K Patel
Journal:  Med J Armed Forces India       Date:  2019-05-03

5.  Study of positional dependence of dose to bladder, pelvic wall and rectal points in High-Dose-Rate Brachytherapy in cervical cancer patients.

Authors:  Anil Kumar Talluri; Krishnam Raju Alluri; Deleep Kumar Gudipudi; Shabbir Ahamed; Madhusudhana M Sresty; Aparna Yarrama Reddy
Journal:  J Med Phys       Date:  2013-10

6.  Interobserver variation in rectal and bladder doses in orthogonal film-based treatment planning of cancer of the uterine cervix.

Authors:  P Raghukumar; K Raghu Ram Nair; B Saju; G Zhenia; K T Divya; V S Shaiju; V Padmanabhan
Journal:  J Med Phys       Date:  2008-10

7.  Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy.

Authors:  Swamidas V Jamema; Sherly Saju; Umesh Mahantshetty; S Pallad; D D Deshpande; S K Shrivastava; K A Dinshaw
Journal:  J Med Phys       Date:  2008-01

8.  A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy.

Authors:  Nicole Nesvacil; Kari Tanderup; Taran P Hellebust; Astrid De Leeuw; Stefan Lang; Sandy Mohamed; Swamidas V Jamema; Clare Anderson; Richard Pötter; Christian Kirisits
Journal:  Radiother Oncol       Date:  2013-04-18       Impact factor: 6.280

Review 9.  Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.

Authors:  Christian Kirisits; Mark J Rivard; Dimos Baltas; Facundo Ballester; Marisol De Brabandere; Rob van der Laarse; Yury Niatsetski; Panagiotis Papagiannis; Taran Paulsen Hellebust; Jose Perez-Calatayud; Kari Tanderup; Jack L M Venselaar; Frank-André Siebert
Journal:  Radiother Oncol       Date:  2013-11-30       Impact factor: 6.280

10.  Investigation of whether in-room CT-based adaptive intracavitary brachytherapy for uterine cervical cancer is robust against interfractional location variations of organs and/or applicators.

Authors:  Yoshifumi Oku; Hidetaka Arimura; Tran Thi Thao Nguyen; Yoshiyuki Hiraki; Masahiko Toyota; Yasumasa Saigo; Takashi Yoshiura; Hideki Hirata
Journal:  J Radiat Res       Date:  2016-06-13       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.